MarketCap
Facebook
X
Telegram
Zoetis DSO Ratio | ZTS
Annual DSO Ratio Zoetis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 51.7 | 53.8 | 53 | 50.4 | 57.4 | 63.3 | 64.9 | 68.6 | 68.2 | 71.8 | 74.8 | 91.1 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.1 | 50.4 | 63.5 |
Quarterly DSO Ratio Zoetis
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.3 | 56.9 | 58.8 | 56.7 | 58 | 53.5 | 55.6 | 53.7 | 53.4 | 51.7 | 54.1 | 52.8 | 54.7 | 52.5 | 54.8 | 53.8 | 56.5 | 55.9 | 54.1 | 53 | 53.2 | 53.8 | 52.1 | 51.1 | 51 | 57.4 | 61 | 57.7 | 58.3 | 57.9 | 62.9 | 57.3 | 58.6 | 61.8 | 64.8 | 62.7 | 67.2 | 69.3 | 69.2 | 65.3 | 66.3 | 67.8 | 72.4 | 70.7 | 76.3 | 73.7 | 78 | 70.4 | 81.3 | 86.6 | 93.1 | 81.8 | 93 | 81.8 | 73.7 | 69.8 | 80.6 | 75.1 | 39.2 | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 93.1 | 39.2 | 63.2 |
DSO Ratio of other stocks in the Biotechnology industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
50 | $ 3.8 | 2.15 % | $ 728 M |  Canada |
 |
Agenus
AGEN
|
3.58 | $ 7.02 | -1.82 % | $ 209 M |  USA |
 |
AbCellera Biologics
ABCL
|
173 | $ 12.44 | -0.52 % | $ 3.72 B | Canada |
 |
Aptevo Therapeutics
APVO
|
79 | $ 1.08 | -4.42 % | $ 341 K | USA |
 |
Aclaris Therapeutics
ACRS
|
7.42 | $ 4.13 | -2.5 % | $ 506 M | USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
60.7 | $ 29.38 | -2.91 % | $ 4.46 B | USA |
 |
Biofrontera AG
BFRA
|
42.2 | - | -8.24 % | $ 105 M |  Germany |
 |
Pliant Therapeutics
PLRX
|
229 | $ 0.78 | -2.19 % | $ 47.9 M | USA |
 |
Capricor Therapeutics
CAPR
|
31.9 | $ 8.91 | -9.54 % | $ 414 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 29.06 | -1.09 % | $ 1.36 B | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
106 | - | 1.68 % | $ 4.65 B |  China |
 |
Aquestive Therapeutics
AQST
|
103 | $ 3.52 | -0.56 % | $ 376 M | USA |
 |
Jaguar Health
JAGX
|
48.3 | $ 0.44 | -0.21 % | $ 1.03 M | USA |
 |
Arvinas
ARVN
|
4.66 | $ 6.9 | 2.07 % | $ 489 M | USA |
 |
Cerus Corporation
CERS
|
47 | $ 1.95 | -6.04 % | $ 372 M | USA |
 |
Pulmatrix
PULM
|
21.7 | $ 1.39 | 2.58 % | $ 5.08 B | USA |
 |
Fortress Biotech
FBIO
|
115 | $ 1.9 | -4.52 % | $ 53 M | USA |
 |
Inhibrx
INBX
|
24.6 | $ 90.63 | -1.21 % | $ 4.27 B | USA |
 |
Entera Bio Ltd.
ENTX
|
548 | $ 3.24 | -0.31 % | $ 150 M |  Israel |
 |
Flexion Therapeutics, Inc.
FLXN
|
129 | - | - | $ 459 M | USA |
 |
Legend Biotech Corporation
LEGN
|
3.53 K | $ 20.25 | -16.63 % | $ 7.46 B | USA |
 |
CytomX Therapeutics
CTMX
|
12.3 | $ 2.0 | 0.76 % | $ 276 M | USA |
 |
Krystal Biotech
KRYS
|
109 | $ 306.47 | 1.13 % | $ 8.87 B | USA |
 |
Kura Oncology
KURA
|
29.4 | $ 7.56 | -0.13 % | $ 663 M | USA |
 |
Inhibikase Therapeutics
IKT
|
27.9 | $ 1.58 | -6.25 % | $ 155 M | USA |
 |
Heron Therapeutics
HRTX
|
198 | $ 0.38 | 1.38 % | $ 63.3 M | USA |
 |
Inovio Pharmaceuticals
INO
|
3.35 K | $ 1.47 | -2.98 % | $ 68.9 M | USA |
 |
Aytu BioScience
AYTU
|
171 | $ 1.83 | 2.23 % | $ 22.5 M | USA |
 |
Heat Biologics, Inc.
HTBX
|
21.9 | - | -5.76 % | $ 99.8 M | USA |
 |
Innoviva
INVA
|
24.6 | $ 19.08 | 0.39 % | $ 1.29 B | USA |
 |
BioCardia
BCDA
|
198 | $ 0.95 | 2.66 % | $ 6.33 M | USA |
 |
Kindred Biosciences, Inc.
KIN
|
5.4 | - | 0.11 % | $ 419 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 2.3 | -5.35 % | $ 14.7 B |  Australia |
 |
Shineco, Inc.
TYHT
|
172 | - | -3.90 % | $ 97.2 M | China |
 |
Certara
CERT
|
89.6 | $ 12.21 | -0.08 % | $ 1.96 B | USA |
 |
Dyadic International
DYAI
|
78.4 | $ 0.39 | 1.16 % | $ 14.1 M | USA |
 |
Anika Therapeutics
ANIK
|
76.5 | $ 13.42 | -7.89 % | $ 192 M | USA |